Mycosis fungoides natural history, complications and prognosis: Difference between revisions
Line 30: | Line 30: | ||
==Staging== | ==Staging== | ||
The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.<ref name="canadiancancer">Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref> Staging for cutaneous T cell lymphoma | The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.<ref name="canadiancancer">Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref> | ||
Staging for cutaneous T cell lymphoma(Mycosis fungoides (MF) and Sezary syndrome have same critera for staging) is provided in the following table: | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" |
Revision as of 16:15, 8 November 2018
Mycosis fungoides Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mycosis fungoides natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Mycosis fungoides natural history, complications and prognosis |
FDA on Mycosis fungoides natural history, complications and prognosis |
CDC on Mycosis fungoides natural history, complications and prognosis |
Mycosis fungoides natural history, complications and prognosis in the news |
Blogs on Mycosis fungoides natural history, complications and prognosis |
Risk calculators and risk factors for Mycosis fungoides natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sogand Goudarzi, MD [3]
Overview
If left untreated, cutaneous T cell lymphoma may progress to develop cutaneous patches, plaque, and tumors. Depending on the extent of the lymphoma at the time of diagnosis, the prognosis may vary.
Natural History
- Mycosis fungoides is initially an indolent lymphoma that may later develop peripheral lymphadenopathy and can finally progress to widespread visceral involvement.[1]
- Cutaneous T cell lymphoma is usually initially seen by dermatologists with patients presenting with skin lesions such as erythematous patches or plaque.
- Patients often have a history of several years of eczematous or dermatitic skin lesions before the diagnosis is finally established.
- The skin lesions then progress from the patch stage to the plaque stage to cutaneous tumors.
Complications
- Common complications of Cutaneous T cell lymphoma include:
- Mycosis Fungoides increased risk of secondary malignancies such as primary malignancy, especially Hodgkin lymphoma, chronic leukemia, and lung cancer.[2]
- [Complication 2]
- [Complication 3]
Prognosis
- Cutaneous T cell lymphoma is usually a slow-growing (indolent) lymphoma.[3]
- The prognosis for people with cutaneous T cell lymphoma is based on the extent of disease and how the person responds to treatment.
- Although more advanced stages of cutaneous T cell lymphoma may not be cured, the lymphoma can still be controlled with treatment.
Favorable prognosis
- Early stage disease
- Lymphoma is confined to the skin
Unfavorable prognosis
- More advanced disease
- Lymphoma has spread to lymph nodes
- Lymphoma has spread to other organs
Staging
The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.[3]
Staging for cutaneous T cell lymphoma(Mycosis fungoides (MF) and Sezary syndrome have same critera for staging) is provided in the following table:
Stage | Involvement | |
---|---|---|
stage I | ||
I A |
| |
I B |
| |
stage II | ||
II A |
| |
II B |
| |
stage III | ||
III |
| |
stage IV | ||
IV A |
| |
IV B |
|
References
- ↑ Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 20, 2016
- ↑ Cengiz FP, Emiroğlu N, Onsun N (December 2017). "Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides". Turk J Haematol. 34 (4): 378–379. doi:10.4274/tjh.2017.0234. PMC 5774354. PMID 28832009.
- ↑ 3.0 3.1 3.2 Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016